Mark A. Hillman - Hillman Value Fund Portfolio (Q2 2026)
Hillman Value Fund, Mark A. Hillman, has built a diversified portfolio of 53 publicly traded holdings with a total market value of $138.15M, according to the SEC 13F filed on Aug 14, 2026 (holdings as of quarter-end Jun 30, 2026). This analysis examines that filing to understand the investment strategy and recent portfolio adjustments.
The portfolio demonstrates a diversified approach to stock selection, with the top holding representing 4.2% of the total portfolio value. The top 5 holdings account for 18.8% of the overall portfolio allocation.
Recent portfolio activity shows 10 significant position adjustments, indicating active portfolio management and strategic repositioning. These changes reflect the investor's response to market conditions and evolving investment thesis.
Portfolio Statistics
Top Holdings Analysis
The portfolio's top holdings reveal the investor's core investment thesis and sector preferences. The largest position in CVS HEALTH CORP (CVS) represents 4.2% of the total portfolio, valued at $5.7M.
| Rank | Symbol | Company | Value | Portfolio % | Change |
|---|---|---|---|---|---|
| 1 | CVS | CVS HEALTH CORP | $5.7M | 4.2% | -17.8% |
| 2 | BIIB | BIOGEN INC | $5.2M | 3.8% | -18.8% |
| 3 | WBD | WARNER BROS DISCOVERY INC | $5.1M | 3.7% | -3.2% |
| 4 | BAX | BAXTER INTL INC | $5.0M | 3.6% | -4.6% |
| 5 | IFF | INTERNATIONAL FLAVORS&FRAGRA | $5.0M | 3.6% | -13.6% |
For a complete analysis of all holdings and detailed portfolio breakdown by sector and market cap, visit our comprehensive holdings page.
Recent Portfolio Activity
Recent portfolio adjustments provide insights into the investor's evolving strategy and market outlook.
The following table shows the top 10 most significant position changes from
recent reporting periods (out of 191 total transactions), sorted by the magnitude of
change.
For a complete history of all portfolio transactions and detailed activity analysis,
visit our comprehensive
activity page.
| Symbol | Company | Quantity Change | Date | Action |
|---|---|---|---|---|
| DD | DuPont de Nemours, Inc. | -117,901 | Jun 30, 2026 | SELL |
| CAG | ConAgra Brands, Inc. | +33,089 | Jun 30, 2026 | BUY |
| TROW | T. Rowe Price Group, Inc. | -22,292 | Jun 30, 2026 | SELL |
| KMX | CarMax Inc | -17,796 | Jun 30, 2026 | SELL |
| VEEV | Veeva Systems Inc. | +14,008 | Jun 30, 2026 | BUY |
| PFE | Pfizer, Inc. | -13,327 | Jun 30, 2026 | SELL |
| CVS | CVS Health Corporation | -11,987 | Jun 30, 2026 | SELL |
| BAX | Baxter International Inc. | -11,288 | Jun 30, 2026 | SELL |
| USB | U.S. Bancorp | -11,276 | Jun 30, 2026 | SELL |
| BWX | SPDR Bloomberg International Tr | -10,384 | Jun 30, 2026 | SELL |
Investment Strategy Insights
Hillman Value Fund's investment approach can be analyzed through several key metrics. The portfolio's concentration in top holdings suggests a diversified investment strategy, with significant positions in companies that align with the investor's long-term thesis.
The largest position in CVS HEALTH CORP (CVS) demonstrates strong conviction in this particular investment opportunity. Recent activity shows a decrease of 17.8% in this position, indicating active portfolio management and strategic positioning.
Portfolio turnover can be assessed through recent activity patterns. The 10 most significant transactions shown here (out of 191 total transactions) suggest a highly active approach to portfolio management, with frequent strategic adjustments and position changes.
Additional Analysis
Complete Holdings
View all 53 holdings with detailed analysis
Trading Activity
Track all portfolio transactions and position changes
Performance Metrics
Analyze profit, winning trades, and investment returns
Sector Allocation
Analyze portfolio breakdown by sector and industry
Hillman Value Fund's portfolio as of Jun 30, 2026 reflects a strategic approach to equity investing with 53 holdings valued at $138.2M. The concentrated position in CVS HEALTH CORP and other top holdings demonstrates the investor's confidence in specific investment themes and long-term value creation opportunities. Recent activity indicates ongoing portfolio optimization and strategic repositioning.
For the most current portfolio data and detailed analysis, refer to the latest SEC 13F filings and our comprehensive holdings and activity pages, which are updated regularly with the latest filing information.
Other Investor Portfolios
- Alex Roepers
- Bill Gates
- Bill Miller
- Chuck Akre
- David Abrams
- David Jeffrey Fear
- David Lemons
- Dennis Hong
- Donald Yacktman
- Frederick (Shad) Rowe
- Henry Ellenbogen
- Howard Marks
- Jeffrey Ubben
- John Armitage
- Leopold Aschenbrenner
- Mark Massey
- Mason Hawkins
- Michael Burry
- Michael Lindsell, Nick Train
- Peter Thiel
- Richard S. Fuld
- Sarah Ketterer
- Stuart Mclaughlin
- Thomas Graham, Alan, Irving Kahns